What are the recent financial highlights of J B CHEMICALS AND PHARMA?

J B CHEMICALS AND PHARMA recently reported a total revenue of ₹3,830.24 Cr and a net profit margin of 16.71%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of J B CHEMICALS AND PHARMA?

J B CHEMICALS AND PHARMA offers a dividend yield of 1.11%, with a dividend rate of ₹17.0 per share.

What are the key financial metrics of J B CHEMICALS AND PHARMA?

Key financial metrics include a trailing P/E ratio of 36.39234, forward P/E of 27.48613, book value of ₹206.825, price-to-book ratio of 7.0769973, and a market capitalization of ₹227.86 billion.

What does J B CHEMICALS AND PHARMA do?

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Jbchepharm

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Jbchepharm

Latest updates related to Jbchepharm

Sr No.	Title	Sentiment
1	Institutions along with private equity firms who hold considerable shares inJ. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) come under pressure; lose 4.3% of holdings value Simply Wall St	🔄
2	HOT STOCKS: NH Hits All-Time High, BLUESTARCO & DBL Lead Gainers, While HIKAL, SEQUENT, and JBCHEPHARM Drag; Key Moving Averages in Focus MarketSmith India	🔄
3	Private equity firms who have a significant stake must be disappointed along with institutions after J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) market cap dropped by ₹16b Simply Wall St	🔄
4	J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) investors will be pleased with their incredible 712% return over the last five years Simply Wall St	🔄
5	Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation Simply Wall St	🔄
6	HOT STOCKS: NH Hits All-Time High, BLUESTARCO & DBL Lead Gainers, While HIKAL, SEQUENT, and JBCHEPHARM Drag; Key Moving Averages in Focus MarketSmith India	🔄
7	HOT STOCKS: NH Hits All-Time High, BLUESTARCO & DBL Lead Gainers, While HIKAL, SEQUENT, and JBCHEPHARM Drag; Key Moving Averages in Focus MarketSmith India	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

VESUVIUS IL&FSENGG LPDC CELLPOINT HERANBA IOC CMICABLES DKEGL TAPIFRUIT DREDGECORP